160 related articles for article (PubMed ID: 11090651)
1. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide.
Ball AJ; Flatt PR; McClenaghan NH
Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651
[TBL] [Abstract][Full Text] [Related]
2. Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposure.
McClenaghan NH; Ball AJ; Flatt PR
Biochem Pharmacol; 2001 Mar; 61(5):527-36. PubMed ID: 11239495
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin on BRIN-BD11 beta-cell insulin secretory desensitization induced by prolonged exposure to sulphonylureas.
Irwin N; McKinney JM; Bailey CJ; Flatt PR; McClenaghan NH
Diabetes Obes Metab; 2010 Dec; 12(12):1066-71. PubMed ID: 20977577
[TBL] [Abstract][Full Text] [Related]
4. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
[TBL] [Abstract][Full Text] [Related]
5. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC
Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced desensitization of insulinotropic actions of sulfonylureas.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Biochem Biophys Res Commun; 2000 Apr; 271(1):234-9. PubMed ID: 10777708
[TBL] [Abstract][Full Text] [Related]
7. Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide.
McClenaghan NH; Ball AJ; Flatt PR
Br J Pharmacol; 2000 May; 130(2):478-84. PubMed ID: 10807689
[TBL] [Abstract][Full Text] [Related]
8. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
Lee K; Ozanne SE; Hales CN; Ashford ML
Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the secretory properties of four insulin-secreting cell lines.
Hamid M; McCluskey JT; McClenaghan NH; Flatt PR
Endocr Res; 2002; 28(1-2):35-47. PubMed ID: 12108788
[TBL] [Abstract][Full Text] [Related]
10. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
[TBL] [Abstract][Full Text] [Related]
11. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
Anello M; Gilon P; Henquin JC
Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
[TBL] [Abstract][Full Text] [Related]
12. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Chapman JC; McClenaghan NH; Cosgrove KE; Hashmi MN; Shepherd RM; Giesberts AN; White SJ; Ammälä C; Flatt PR; Dunne MJ
Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
[TBL] [Abstract][Full Text] [Related]
13. Insulin release from pancreatic islets of fetal rats mediated by leucine b-BCH, tolbutamide, glibenclamide, arginine, potassium chloride, and theophylline does not require stimulation of Ca2+ net uptake.
Ammon HP; Glocker C; Waldner RG; Wahl MA
Cell Calcium; 1989; 10(6):441-50. PubMed ID: 2505929
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
Zawalich WS
Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
[TBL] [Abstract][Full Text] [Related]
15. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
16. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets.
Gullo D; Rabuazzo AM; Vetri M; Gatta C; Vinci C; Buscema M; Vigneri R; Purrello F
J Endocrinol Invest; 1991 Apr; 14(4):287-91. PubMed ID: 1907623
[TBL] [Abstract][Full Text] [Related]
18. Comparative functional study of clonal insulin-secreting cells cultured in five commercially available tissue culture media.
Hamid M; McCluskey JT; McClenaghan NH; Flatt PR
Cell Transplant; 2001; 10(2):153-9. PubMed ID: 11332629
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line.
McClenaghan NH; Barnett CR; O'Harte FP; Flatt PR
J Endocrinol; 1996 Dec; 151(3):349-57. PubMed ID: 8994380
[TBL] [Abstract][Full Text] [Related]
20. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
